Zika Virus
Infectious Disease·MeSH: Zika Virus Infection
Prevalence
30.0 / 100K
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| autovac | Orgenesis Inc. (ORGS) |
Phase 4(1)
| Drug | Company |
|---|---|
| mRNA-1893 | Moderna, Inc. (MRNA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Zika Virus?
BioSniper tracks 2 drugs in development for Zika Virus across 2 companies.
How many clinical trials target Zika Virus?
There are 1 clinical trial targeting Zika Virus tracked by BioSniper.
What is the prevalence of Zika Virus?
The estimated prevalence of Zika Virus is approximately 30.0 per 100,000 population.
Deep-dive into Zika Virus
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis